Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
25.32
-0.40 (-1.56%)
Dec 3, 2024, 12:29 PM EST - Market open

Arvinas Revenue

Arvinas had revenue of $102.40M in the quarter ending September 30, 2024, with 195.95% growth. This brings the company's revenue in the last twelve months to $161.10M, up 1.07% year-over-year. In the year 2023, Arvinas had annual revenue of $78.50M, down -40.26%.

Revenue (ttm)
$161.10M
Revenue Growth
+1.07%
P/S Ratio
11.05
Revenue / Employee
$362,022
Employees
445
Market Cap
1.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 202025.90M-17.10M-39.77%
Dec 31, 201943.00M28.68M200.20%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
GoodRx Holdings 790.39M
Certara 372.80M
Galapagos NV 290.09M
MannKind 267.20M
RxSight 128.29M
Xencor 85.16M
NewAmsterdam Pharma Company 33.59M
Revenue Rankings